SEC Filing Details

Document Details

Form
Filing Date
Mar 17, 2023
Document Date
Mar 15, 2023
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
G1 Therapeutics, Inc.
Issuer
G1 Therapeutics, Inc.
Filer
UMSTEAD JOHN V.